On July 22, 2019, ASIT Biotech S.A. (ENXTBR:ASIT) closed the transaction. The company has received €9,225,000 in the transaction. The notes issued in the transaction were senior and unsecured. The notes will mature on December 31, 2020 and will bear an interest rate of 3% per annum. The shares issued upon conversion of notes will be subject to a lock-up period of 6 months.